Health Catalyst stock hits 52-week low at $4.7 amid market challenges

Published 27/02/2025, 15:32
Updated 27/02/2025, 15:34
Health Catalyst stock hits 52-week low at $4.7 amid market challenges

In a turbulent market environment, Health Catalyst Inc. (NASDAQ:HCAT) stock has touched a 52-week low, dipping to $4.61, with a market capitalization of $300.59 million. The healthcare data and analytics company has faced significant headwinds over the past year, with a steep decline of -40.55%. According to InvestingPro analysis, the stock’s RSI indicates oversold territory, suggesting potential for a technical rebound. Investors have shown concern as the stock struggles to regain momentum amidst a broader industry downturn. The current price level marks a critical juncture for the company, as it seeks to navigate through the challenges and reposition itself for future growth. Notably, analyst price targets range from $6 to $16, suggesting significant upside potential. For deeper insights and additional ProTips about HCAT’s valuation and growth prospects, explore the comprehensive research available on InvestingPro.

In other recent news, Health Catalyst reported its fourth-quarter financial results, showing a revenue of $79.6 million, which was slightly below the anticipated $80.68 million. The company’s earnings per share (EPS) significantly missed expectations, posting a loss of $0.33 against a forecasted profit of $0.07. Despite the earnings miss, Health Catalyst saw a 6% year-over-year revenue increase, with technology revenue growing by 10%. BTIG analysts responded by reducing the price target for Health Catalyst shares to $10, while maintaining a Buy rating. They noted that the company’s adjusted EBITDA surged by 485% year-over-year to $7.9 million, although it fell slightly short of BTIG’s estimate. Health Catalyst reaffirmed its 2025 revenue guidance at approximately $335 million, slightly below the consensus estimate. The company also raised its 2025 EBITDA guidance to around $41 million from $39 million. Health Catalyst’s management emphasized that, despite near-term pressure on margins due to ongoing transitions, they expect earnings to strengthen throughout the year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.